Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 208
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...
Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying...
Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member
Small Pharma Reports Fiscal Third Quarter 2021 Highlights
IntelGenx Receives Third Loan Tranche from atai
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results...
Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares...
Numinus Appoints New Bioscience Advisors to Advance IP Development
PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status...
Load more